MILLENNIUM MANAGEMENT LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1273087 NEW YORK, NY

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$164,338,667

+$101,526,983 QoQ

Shares Held

1,247,447

+181.7% QoQ

Ownership

1.24%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Derivatives in NBIX

reported options exposure · as of Sep 30, 2025

CallValue

CallShares

PutValue

$7,117,266

PutShares

50,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $1,131,904,343 across 44 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (14.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,649,955	$195,041,180
2	SUPN	Supernus Pharmaceuticals, Inc.	3,315,973	$171,402,644
3	NBIX	Neurocrine Biosciences Inc This page	1,247,447	$164,338,667
4	INDV	Indivior Pharmaceuticals, Inc.	4,595,535	$140,071,906
5	UTHR	UNITED THERAPEUTICS Corp	153,372	$90,946,528
6	TEVA	Teva Pharmaceutical Industries Ltd	1,893,845	$57,042,611
7	PRGO	PERRIGO Co plc	4,279,731	$45,964,310
8	ANIP	Ani Pharmaceuticals Inc	592,013	$45,525,799

All Filings in NBIX

Export CSV

36 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$164,338,667	1,247,447	+181.7%	Shares	Sole	2026-05-15
2025-12-31	$62,811,684	442,866	+773.5%	Shares	Sole	2026-02-17
2025-09-30	$7,117,266	50,700	-94.8%	Put	Sole	2025-11-14
2025-09-30	$137,180,739	977,210	-18.2%	Shares	Sole	2025-11-14
2025-06-30	$150,101,386	1,194,219	+107.1%	Shares	Sole	2025-08-14
2025-03-31	$63,770,854	576,590	+1137.3%	Shares	Sole	2025-05-15
2025-03-31	$5,153,960	46,600	-88.9%	Call	Sole	2025-05-15
2024-12-31	$57,154,188	418,712	+4658.1%	Shares	Sole	2025-02-14
2024-12-31	$1,201,200	8,800	+23.9%	Put	Sole	2025-02-14
2024-12-31	$969,150	7,100	-62.0%	Call	Sole	2025-02-14
2024-09-30	$2,154,614	18,700	-94.0%	Put	Sole	2024-11-14
2024-09-30	$36,037,013	312,767	+66.8%	Shares	Sole	2024-11-14
2024-06-30	$25,810,784	187,483	+74.4%	Shares	Sole	2024-08-14
2024-06-30	$14,799,525	107,500	-76.4%	Call	Sole	2024-08-14
2024-03-31	$62,783,942	455,220	-33.9%	Shares	Sole	2024-05-15
2023-12-31	$90,776,842	688,956	+4493.0%	Shares	Sole	2024-02-14
2023-09-30	$1,687,500	15,000	-98.8%	Put	Sole	2023-11-14
2023-09-30	$142,679,925	1,268,266	+49.2%	Shares	Sole	2023-11-14
2023-06-30	$80,179,329	850,258	+49.6%	Shares	Sole	2023-08-14
2023-03-31	$57,520,795	568,275	-32.4%	Shares	Sole	2023-05-15
2022-12-31	$100,370,209	840,340	+46.6%	Shares	Sole	2023-02-14
2022-09-30	$60,864,277	573,056	+58.0%	Shares	Sole	2022-11-14
2022-06-30	$35,353,364	362,673	-27.5%	Shares	Sole	2022-08-15
2022-03-31	$46,886,906	500,127	+733.5%	Shares	Sole	2022-05-16
2021-12-31	$5,110,200	60,000	-89.3%	Call	Sole	2022-02-14
2021-12-31	$47,780,114	560,997	+319.6%	Shares	Sole	2022-02-14
2021-09-30	$12,823,167	133,700	-72.8%	Call	Sole	2021-11-15
2021-09-30	$47,115,212	491,244	+304.3%	Shares	Sole	2021-11-15
2021-06-30	$11,825,450	121,511	-19.0%	Shares	Sole	2021-08-16
2021-06-30	$14,598,000	150,000	0.0%	Call	Sole	2021-08-16
2021-03-31	$14,587,500	150,000	-33.4%	Call	Sole	2021-05-17
2020-12-31	$21,581,202	225,156	+1910.3%	Shares	Sole	2021-02-16
2020-12-31	$1,073,520	11,200	-73.7%	Call	Sole	2021-02-16
2020-09-30	$4,099,877	42,636	-27.9%	Shares	Sole	2020-11-16
2020-06-30	$7,216,300	59,150	-49.4%	Shares	Sole	2020-08-14
2020-03-31	$10,109,040	116,800	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.